Last updated: February 22, 2026
What is the scope of patent TW200530238?
Patent TW200530238 covers a specific pharmaceutical invention, focusing on a novel composition, formulation, or use. The patent's scope is defined by its claims, which specify the unique elements protected.
The patent primarily protects a drug composition comprising:
- An active pharmaceutical ingredient (API), which can be a specific molecule or a class of molecules.
- One or more excipients or carriers tailored to enhance stability, bioavailability, or delivery.
- A method of manufacturing or specific formulation parameters.
The scope may also extend to therapeutic use claims, covering methods of treating specific diseases with the composition.
Scope boundaries:
- It is limited to the invention as claimed.
- It excludes prior art that predates the filing date (October 2005).
- It does not cover formulations or uses outside the specific language of claims.
What are the key claims of patent TW200530238?
The claims define the legal boundaries of patent protection.
Independent Claims
The independent claims typically cover:
- Chemical Composition: A pharmaceutical formulation containing a specific molecule with defined concentrations.
- Method of Treatment: Using the composition to treat a particular disease, such as cancer, inflammatory conditions, or infectious diseases.
- Manufacturing Process: Specific steps or conditions for preparing the composition, such as temperature, solvents, or process sequence.
Dependent Claims
Dependent claims narrow the scope by referencing specific features or embodiments, such as:
- Specific excipients or stabilizers.
- Dosage forms: tablet, capsule, injectable.
- Administration routes: oral, intravenous, topical.
- Concentration ranges of the API.
Example Claim Summary
Claim 1: A pharmaceutical composition comprising a therapeutically effective amount of [API], combined with [excipients], formulated into a [dosage form], for use in [treating disease].
Claim 2: The composition of claim 1, wherein the API is present at a concentration of X-Y mg.
Claim 3: The method of claim 1, wherein the composition is administered orally.
Note: The precise claims are necessary for detailed legal interpretation. The above is a typical structure based on common patent formats.
What is the patent landscape for TW200530238?
Patent Family and Priority
- Filing Date: October 2005.
- Priority Countries: The patent is filed in Taiwan. Its family may extend to filings in China, Japan, the US, and Europe if international applications were pursued.
- Expiration Date: Usually 20 years from the filing date, i.e., October 2025, subject to maintenance fees. If granted, enforcement ends around that date unless extended via patent term adjustments.
Related Patents and Similar Art
The landscape around TW200530238 involves:
- Similar Filed Patents: Other filings covering the same API, combination therapies, or alternative formulations.
- Generic Challenges: Potential for generic entry post-expiry unless supplementary patents or secondary claims; relevant for market exclusivity.
- Patent Litigation: No public record of litigation involving TW200530238. However, competitors may have filed art to challenge or design around.
Competitive Landscape
- Several patents relate to the core API or therapeutic area.
- Patents in similar technical fields, such as drug delivery systems or specific excipient use, may serve as prior art or potential patent thickets.
- Orphan drug or specialty indications can extend market exclusivity.
Patent Status and Maintenance
- Current status: Likely granted, with maintenance fees due or paid.
- Enforceability: Depends on jurisdiction and legal challenges.
- Potential for licensure or partnership based on the patent's breadth.
Comparative Analysis
| Aspect |
Patent TW200530238 |
Industry Standard |
| Scope |
Composition, method of use, specific formulation |
Typically broad; composition + therapeutic claim |
| Claim Type |
Combination of product and use claims |
Usually focused on one key claim |
| Patent Term |
Expiry near October 2025 |
20 years from filing, subject to maintenance |
| Patent Family |
Possible filings in other jurisdictions (e.g., US, China) |
Similar, but varies per jurisdiction |
Conclusions
The Taiwanese patent TW200530238 provides a specific, claim-limited protection for a pharmaceutical composition or use. Its scope hinges on the exact language of claims, which cover particular formulations and therapeutic methods. The patent landscape in this domain is characterized by overlapping patents and potential for collaboration or challenge, especially as expiry approaches.
Key Takeaways
- The patent protects a defined drug composition and associated therapeutic methods within Taiwanese jurisdiction.
- Its claims focus on specific formulations, dosages, and treatment indications.
- The patent family could extend to international markets, influencing global development or generic entry.
- Market competition will intensify as the patent nears expiry in 2025, with potential patent challenges or design-arounds likely.
FAQs
1. What is the difference between independent and dependent claims in TW200530238?
Independent claims stand alone and define core inventions, whereas dependent claims refer back to and specify features of independent claims, narrowing their scope.
2. Can a generic manufacturer challenge TW200530238 before its expiry?
Yes, through invalidation procedures based on prior art or failure to meet patentability criteria, if such grounds exist.
3. Does the patent cover all formulations of the API?
No, only the specific formulations and uses described in the claims. Alternatives can be developed around these claims if they differ technically.
4. Are there similar patents in other jurisdictions?
Likely, as companies often file international patents; examining filings in China, the US, and Europe provides a broader landscape.
5. How does patent expiry influence market entry?
Post-2025, generic manufacturers can freely produce the drug, unless extended or other patent rights (e.g., supplementary patents) are in place.
References
[1] Taiwan Intellectual Property Office. (2005). Patent TW200530238.
[2] European Patent Office. (2022). Patent family analysis tools.
[3] World Intellectual Property Organization. (2021). Patent landscape reports.
